Metallothionein 3: An androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells

Prostate

Volumn 73, Issue 14, 2013, Pages 1495-1506

  Juang, Horng Heng ^a,b   Chung, Li Chuan ^a   Sung, Hsin Ching ^a   Feng, Tsui Hsia ^a   Lee, Yi Hua ^a   Chang, Phei Lang ^b   Tsui, Ke Hung ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

androgen; maspin; metallothionein; Ndrg1; prostate

Indexed keywords

ANDROGEN; ARSENIC; CADMIUM; DOXORUBICIN; MASPIN; METALLOTHIONEIN III;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SIZE; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; EXPRESSION VECTOR; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSIENT EXPRESSION; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ANDROGEN; MASPIN; METALLOTHIONEIN; NDRG1; PROSTATE;

ANDROGENS; ANIMALS; ARSENIC; CADMIUM; CARCINOGENESIS; CARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ENHANCEMENT; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METALLOTHIONEIN; MICE; PROSTATIC NEOPLASMS; SERPINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84883164202     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22697     Document Type: Article

References (35)

1. Miles AT, Hawksworth GM, Beattie JH, Rodilla V,. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35: 35-70.
2. Stennard FA, Holloway AF, Hamilton J, West AK,. Characterization of six additional human metallothionein genes. Biochim Biophys Acta 1994; 1218: 357-365.
3. Palmiter RD, Findley SD, Whitmore TE, Durnam DM,. MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci 1992; 89: 6333-6337.
4. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP, Palmiter RD,. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994; 33: 7250-7259.
5. Pedersen M, Larsen A, Stoltenberg M, Penkowa M,. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009; 44: 29-64.
6. Tekur S,., Ho SM,. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines. Mol Carcinog 2002; 33: 44-55.
7. El Sharkawy SL, Abbas NF, Badawi MA, El Shaer MA,. Metallothionein isoform II expression in hyperplastic, dysplastic and neoplastic prostatic lesions. J Clin Pathol 2006; 59: 1171-1174.
8. Athanassiadou P, Bantis A, Gonidi M, Athanassiades P, Agelonidou E, Grapsa D, Nikolopoulou P, Patsouris E,. The expression of metallothioneins on imprint smears of prostate carcinoma: Correlation with clinicopathologic parameters and tumor proliferative capacity. Tumori 2007; 93: 189-194.
9. Krizkova S, Ryvolova M, Gumulec J, Masarik M, Adam V, Majzlik P, Hubalek J, Provaznik I, Kizek R,. Electrophoretic fingerprint metallothionein analysis as a potential prostate cancer biomarker. Electrophoresis 2011; 32: 1952-1961.
10. Wei H, Desouki MM, Lin S, Xiao D, Franklin RB, Feng P,. Differential expression of metallothioneins (MTs) 1, 2 and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues. Mol Cancer 2008; 7: 7.
11. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S,. Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008; 68: 1152-1164.
12. Hasumi M, Suzuki K, Matsui H, Koike H, Ito K, Yamanaka H,. Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues. Cancer Lett 2003; 200: 187-195.
13. Albrecht AL, Singh RK, Somji S, Sens MA, Sens DA, Garrett SH,. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line. J Appl Toxicol 2008; 28: 283-293.
14. Cyr DG, Dufresne J, Pillet S, Alfieri TJ, Hermo L,. Expression and regulation of metallothioneins in the rat epididymis. J Androl 2001; 22: 124-135.
15. Moffatt P, Seguin C,. Expression of the gene encoding metallothionein-3 in organs of the reproductive system. DNA Cell Biol 1998; 17: 501-510.
16. Iguchi K, Morihara N, Usui S, Hayama M, Sugimura Y, Hirano K,. Castration- and aging-induced changes in the expression of zinc transporter and metallothionein in rat prostate. J Androl 2011; 32: 144-150.
17. Tsui KH, Chang YL, Feng TH, Chang PL, Jaung HH,. Glycoprotein transmembrane nmb: An androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells. Prostate 2012; 72: 1431-1442.
18. Tsui KH, Feng TH, Lin YF, Chang PL, Juang HH,. p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate 2011; 71: 62-70.
19. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Jaung HH,. Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol Nutr Food Res 2011; 55: 1666-1676.
20. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Jaung HH,. l -Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell Physiol 2012; 302: C676-C685.
21. Tsui KH, Chung LC, Feng TH, Chang PL, Jaung HH,. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. Int J Cancer 2012; 130: 2812-2823.
22. Tsui KH, Chang YL, Feng TH, Chung LC, Lee TY, Chang PL, Jaung HH,. Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells. J Mol Endocrinol 2012; 49: 153-163.
23. Yamasaki M, Nomura T, Sato F, Mimata H,. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells. Oncol Rep 2007; 18: 1145-1153.
24. +2-transformed human urothelial cells. Toxicol Sci 2006; 93: 322-330.
25. Sens MA, Somji S, Garrett SH, Beall CL, Sens DA,. Methallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis. Am J Pathol 2001; 159: 21-26.
26. Dutta R, Sens DA, Somji S, Sens MA, Garrett SH,. Metallothionein isoform 3 inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells. Prostate 2002; 52: 89-97.
27. Garrett SH, Sens MA, Shukla D, Nestor S, Somji S, Todd JH, Sens DA,. Methallothionein isoform 3 expression in the human prostate and cancer-derived cell lines. Prostate 1999; 41: 196-202.
28. Wang G, Fowler BA,. Roles of biomarkers in evaluating interactions among mixture of lead, cadmium and arsenic. Toxicol Appl Pharmacol 2008; 233: 92-99.
29. Klaassen CD, Liu J, Diwan BA,. Metallothionein protection of cadmium toxicity. Toxicol Appl Pharmacol 2009; 238: 215-220.
30. Bataineh ZM, Nusier MK,. Metallothionein expression in human prostate gland. Saudi Med J 2003; 24: 1246-1249.
31. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, Watabe K,. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 2003; 63: 1731-1736.
32. Bernardo MM, Meng Y, Lockett J, Dyson G, Dombkowski A, Kaplun A, Li X, Yin S, Dzinic S, Olive M, Dean I, Krass D, Moin K, Bonfil RD, Cher M, Sakr W, Sheng S,. Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation. Genes Cancer 2012; 2: 1009-1022.
33. Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar K, Li Y, Sarkar ZH, Reddy GPV, Dou QP, Sheng S,. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol 2007; 212: 298-306.
34. Hwang YP, Kim HG, Han EH, Jeong HG,. Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner. Toxicol Appl Pharmacol 2008; 231: 318-327.
35. Kim HG, Hwang YP, Han EH, Choi CY, Yeo CY, Kim JY, Lee KY, Jeong HG,. Metallothionein-III provides neuronal protection through activation of nuclear factor-kappaB via the Trk/phosphatidylinositol-3 kinase/Akt signaling pathway. Toxicol Sci 2009; 112: 435-449.